Smartlab Europe

Press Releases

Virpax Pharmaceuticals Partners with MedPharm for Successful Completion of Pre-IND Meeting with FDA on Epoladerm

Virpax Pharmaceuticals Inc., a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems, has announced that it had successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. FDA for Epoladerm...

AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine

AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner. The Company...

Abivax gets approval to conduct Covid-19 trial in France

Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a Phase IIb/III clinical trial of ABX464 in Covid-19 patients. The miR-AGE trial will assess the drug...

Indica Labs and Octo launch COVID digital pathology repository to support the fight against COVID-19

Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution...

Roche’s Tecentriq receives US FDA approval for first-line monotherapy for certain people with metastatic NSCLC

Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or...

Covis Pharma begins phase 3 study of asthma drug, Alvesco to treat COVID-19

Covis Pharma announced the initiation of a phase 3 clinical study to assess the safety and efficacy of its asthma drug Alvesco (ciclesonide) in non-hospitalized patients 12 years of age and older with symptomatic COVID-19. Patient recruitment for the...

UPS Healthcare Provides Urgent Support For Dr. Reddys Laboratories Temperature-Sensitive Medicines

UPS announced a collaboration with Dr. Reddy’s Laboratories to get 30 tons of pharmaceuticals from India to the United States via Europe. The sensitive cargo had to be shipped within a controlled temperature range to ensure product stability. Given...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »